Recent Advances on the Possible Neuroprotective Activities of Epstein- Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|8|3|268-275

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.8, Iss.3, 2010-09, pp. : 268-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders

By  

Current Medicinal Chemistry, Vol. 16, Iss. 19, 2009-07 ,pp. : 2373-2394

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in the prevention and treatment of Epstein–Barr virus-associated lymphoproliferative diseases

By Meerbach Astrid   Gruhn Bernd   Wutzler Peter  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 527-547

Informa Healthcare

Access to resources Recommend Favorite

Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 233-252

Bentham Science Publishers

Access to resources Recommend Favorite

Annexins as Neuroprotective Agents in the Central Nervous System

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 87-107

Bentham Science Publishers

Access to resources Recommend Favorite

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite